The Registry of Toxic Effects of Chemical Substances
Bromic acid, potassium salt |
UPDATE: August 2004 | MW: 167.01 | MF: BrO3•K |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
hamster
lung
|
85 mg/L
|
GMCRDC 27,95,1981
|
cytogenetic analysis
|
intraperitoneal | rat
251 mg/kg
|
MUREAV 240,281,1990
|
cytogenetic analysis
|
oral | rat
3 mmol/kg
|
MUREAV 147,274,1985
|
DNA damage
|
hamster
ovary
|
7.195 mmol/L/4 hour
|
EMMUEG 40,134,2002
|
DNA damage
|
hamster
ovary
|
2.5 mmol/L/3 hour
|
FCTOD7 42,209,2004
|
DNA damage
|
mouse
leukocyte
|
7,500 µmol/L
|
CRNGDP 16,335,1995
|
DNA damage
|
intraperitoneal | mouse
150 mg/kg
|
MUREAV 493,39,2001
|
DNA damage
|
oral | mouse
300 mg/kg
|
MUREAV 493,39,2001
|
DNA damage
|
pig
kidney
|
7,500 µmol/L
|
CRNGDP 16,335,1995
|
DNA damage
|
intraperitoneal | rat
80 mg/kg
|
JJCREP 83,45,1992
|
DNA repair
|
hamster
ovary
|
5 mmol/L/3 hour
|
FCTOD7 42,209,2004
|
mutation in microorganisms
|
Salmonella typhimurium
|
3,333 µg/plate (+enzymatic activation step)
|
EMMUEG 19(Suppl 21),2,1992
|
mutation in microorganisms
|
Salmonella typhimurium
|
1 mg/plate (-enzymatic activation step)
|
AMONDS 3,253,1980
|
micronucleus test
|
hamster
lung
|
125 mg/L
|
MUREAV 272,223,1992
|
micronucleus test
|
hamster
ovary
|
5 mmol/L/3 hour
|
FCTOD7 42,209,2004
|
micronucleus test
|
intraperitoneal | mouse
25 mg/kg
|
FCTOD7 26,487,1988
|
micronucleus test
|
oral | mouse
200 mg/kg/24 hour- continuous
|
FCTOD7 26,487,1988
|
micronucleus test
|
oral | mouse
87.4 gm/kg/78 week- continuous
|
EMMUEG 36,283,2000
|
micronucleus test
|
oral | mouse
4.48 gm/kg/8 week- continuous
|
EMMUEG 36,283,2000
|
micronucleus test
|
intraperitoneal | rat
60 mg/kg
|
MUREAV 269,113,1992
|
sister chromatid exchange
|
rat
leukocyte
|
20 µmol/L
|
MUREAV 300,241,1993
|
specific locus test
|
mouse
other cell types
|
100 mg/L/4 hour
|
MUREAV 537,21,2003
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | rat
lowest published toxic dose: 4,200 mg/kg/13 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Gastrointestinal: Tumors
JJCREP 78,358,1987
|
oral | rat
lowest published toxic dose: 38,500 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors
GANNA2 73,335,1982
|
oral | rat
toxic dose : 19,635 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors Endocrine: Thyroid tumors
ESKHA5 (100),93,1982
|
oral | rat
toxic dose : 19,250 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors
GANNA2 73,335,1982
|
oral | rat
toxic dose : 10,500 mg/kg/39 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Gastrointestinal: Tumors Kidney, Ureter, and Bladder: Kidney tumors
JJCREP 78,358,1987
|
oral | rat
toxic dose : 9,625 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors Endocrine: Thyroid tumors
ESKHA5 (100),93,1982
|
oral | rat
toxic dose : 9,625 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors
EVHPAZ 69,221,1986
|
oral | rat
toxic dose : 5,460 mg/kg/2 year- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors
JJIND8 77,977,1986
|
oral | rat
lowest published toxic dose: 2,400 mg/kg/16 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors Tumorigenic: Increased incidence of tumors in susceptible strains
TXCYAC 187,1,2003
|
oral | rat
lowest published toxic dose: 57.6 gm/kg/16 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors Tumorigenic: Increased incidence of tumors in susceptible strains
TXCYAC 187,1,2003
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lethal dose (50 percent kill): 177 mg/kg
|
N/R
|
MUREAV 223,399,1989
|
intraperitoneal | rat
lethal dose (50 percent kill): 50 mg/kg
|
N/R
|
JACTDZ 13,400,1994
|
oral | child
lowest published toxic dose: 7,125 µL/kg
|
Behavioral: Change in motor activity (specific assay) | Lung, Thorax, or Respiration: Respiratory stimulation Gastrointestinal: Nausea or vomiting
BMJOAE 1,1363,1951
|
oral | hamster
lethal dose (50 percent kill): 388 mg/kg
|
Behavioral: Altered sleep time (including change in righting reflex) | Lung, Thorax, or Respiration: Respiratory stimulation Gastrointestinal: Hypermotility, diarrhea
EVHPAZ 87,309,1990
|
oral | human
lowest published toxic dose: 714 mg/kg
|
Ear: Change in acuity | Gastrointestinal: Nausea or vomiting Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis)
NPRNAY 37,278,1984
|
oral | mouse
lethal dose (50 percent kill): 289 mg/kg
|
N/R
|
MUREAV 223,399,1989
|
oral | rat
lethal dose (50 percent kill): 157 mg/kg
|
Olfaction: Other olfaction effects | Gastrointestinal: Hypermotility, diarrhea
ESKGA2 37,258,1991
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 336 mg/kg/14 day- continuous
|
Blood: Other changes | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
ESKGA2 37,266,1991
|
oral | rat
lowest published toxic dose: 1,260 mg/kg/13 week- continuous
|
Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
EVHPAZ 87,309,1990
|
subcutaneous | guinea pig
lowest published toxic dose: 280 mg/kg/14 day- intermittent
|
Ear: Changes in vestibular functions | Behavioral: Change in motor activity (specific assay)
TXAPA9 177,103,2001
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 40,207,1986
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 73,481,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human No Adequate Data
|
IMEMDT 40,207,1986
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 73,481,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 2B
|
IMEMDT 73,481,1999
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - UNITED KINGDOM
|
Carcinogen, SEP2000
|
|
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 81949; | Number of Industries 6; Total Number of Facilities 132; Number of Occupations 9; Total Number of Employees Exposed 3,252
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 81949; |
Number of Industries 10; Total Number of Facilities 1,458; Number of Occupations 24; Total Number of Employees Exposed 26,562; Total Number of Female Employees Exposed 11,090 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as a food and feed additive, flavor and packaging material
|
On EPA IRIS database
|
|
REFERENCES:
CODEN
|
|
REFERENCE
AMONDS
|
Applied Methods in Oncology. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York,
NY 10017) V.1- 1978-
|
BMJOAE
|
British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR,
UK) V.1- 1857-
|
CRNGDP
|
Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford
OX8 1JJ, UK) V.1- 1980-
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
ESKGA2
|
Eisei Kagaku. Hygienic Chemistry. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo
150, Japan) V.1- 1953-
|
ESKHA5
|
Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei
Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886-
|
EVHPAZ
|
EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents,
Washington, DC 20402) No.1- 1972-
|
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
GANNA2
|
Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher
information, see JJCREP.
|
GMCRDC
|
Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013)
No. 11- 1971-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
JACTDZ
|
Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New
York, NY 10128) V.1-12, 1982-1993. Discontinued.
|
JJCREP
|
Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam,
Netherlands) V.76- 1985-
|
JJIND8
|
JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For
publisher information, see JNCIEQ.
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NPRNAY
|
Nephron. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.1- 1964-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
|